Brief: GT Biopharma Posts Q3 Loss Per Share Of $0.17

GT Biopharma

10/11/2021 23:14

Nov 10 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
    * GT BIOPHARMA INC QTRLY LOSS PER SHARE $0.17
    * GT BIOPHARMA - AS OF SEPT 30, 2021, CO HAD TOTAL CASH,
CASH
EQUIVALENTS OF $35.8 MILLION

Source text for Eikon:  ID:nPn7b9Cbsa 
Further company coverage:  GTBP.O 

 ((Reuters.Briefs@thomsonreuters.com;))